Rüdiger Heicappell

814 total citations
20 papers, 636 citations indexed

About

Rüdiger Heicappell is a scholar working on Surgery, Molecular Biology and Urology. According to data from OpenAlex, Rüdiger Heicappell has authored 20 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Molecular Biology and 6 papers in Urology. Recurrent topics in Rüdiger Heicappell's work include Bladder and Urothelial Cancer Treatments (9 papers), Urological Disorders and Treatments (6 papers) and Epigenetics and DNA Methylation (5 papers). Rüdiger Heicappell is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Urological Disorders and Treatments (6 papers) and Epigenetics and DNA Methylation (5 papers). Rüdiger Heicappell collaborates with scholars based in Germany and United States. Rüdiger Heicappell's co-authors include Kurt Miller, Hans Krause, Carsten Goessl, Markus Müller, Mark Schrader, Bernd F. Straub, M. G. Müller, Kurt W. Miller, Bernhard Heine and Michael Hummel and has published in prestigious journals such as Annals of the New York Academy of Sciences, The Journal of Urology and Fertility and Sterility.

In The Last Decade

Rüdiger Heicappell

20 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rüdiger Heicappell Germany 9 460 235 176 159 65 20 636
Frances M. Martin United States 8 215 0.5× 158 0.7× 99 0.6× 136 0.9× 17 0.3× 13 460
Lucie Hamel Canada 12 181 0.4× 161 0.7× 109 0.6× 24 0.2× 15 0.2× 21 373
Céu Costa Portugal 11 243 0.5× 56 0.2× 57 0.3× 176 1.1× 10 0.2× 22 421
Jian Gu China 10 167 0.4× 54 0.2× 61 0.3× 78 0.5× 12 0.2× 20 310
Lujia Zou China 10 182 0.4× 92 0.4× 127 0.7× 108 0.7× 50 0.8× 26 353
Yi Liao China 14 211 0.5× 85 0.4× 98 0.6× 65 0.4× 34 0.5× 19 358
K Yamanaka Japan 8 104 0.2× 47 0.2× 46 0.3× 64 0.4× 13 0.2× 17 316
Laura N. Mutton United States 9 236 0.5× 204 0.9× 82 0.5× 28 0.2× 20 0.3× 10 380
Alicia Malewska United States 7 218 0.5× 285 1.2× 123 0.7× 56 0.4× 98 1.5× 9 501
Dolores Byrne United States 7 487 1.1× 54 0.2× 440 2.5× 63 0.4× 30 0.5× 9 613

Countries citing papers authored by Rüdiger Heicappell

Since Specialization
Citations

This map shows the geographic impact of Rüdiger Heicappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rüdiger Heicappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rüdiger Heicappell more than expected).

Fields of papers citing papers by Rüdiger Heicappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rüdiger Heicappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rüdiger Heicappell. The network helps show where Rüdiger Heicappell may publish in the future.

Co-authorship network of co-authors of Rüdiger Heicappell

This figure shows the co-authorship network connecting the top 25 collaborators of Rüdiger Heicappell. A scholar is included among the top collaborators of Rüdiger Heicappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rüdiger Heicappell. Rüdiger Heicappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goessl, Carsten, Markus Müller, Rüdiger Heicappell, et al.. (2002). Methylation‐specific PCR for detection of neoplastic DNA in biopsy washings. The Journal of Pathology. 196(3). 331–334. 34 indexed citations
2.
Straub, Bernd F., Markus Müller, Hans Krause, et al.. (2002). Molecular staging of pelvic surgical margins after radical prostatectomy: Comparison of RT-PCR for prostate-specific antigen and telomerase activity. Oncology Reports. 9(3). 545–9. 5 indexed citations
3.
Straub, Bernd F., Markus Müller, Carsten Goessl, et al.. (2002). Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and TUR-P using “light—cycler”—based quantitative real-time PCR. European Urology Supplements. 1(1). 99–99. 6 indexed citations
4.
Straub, Bernd F., Hans Krause, Carsten Goessl, et al.. (2001). Molecular staging of surgical margins after radical prostatectomy by detection of telomerase activity. The Prostate. 49(2). 140–144. 5 indexed citations
5.
Goessl, Carsten, M. G. Müller, Rüdiger Heicappell, Hans Krause, & Kurt Miller. (2001). DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates. Annals of the New York Academy of Sciences. 945(1). 51–58. 111 indexed citations
6.
Goessl, Carsten, Markus Müller, Rüdiger Heicappell, et al.. (2001). DNA-based detection of prostate cancer in urine after prostatic massage. Urology. 58(3). 335–338. 114 indexed citations
7.
Straub, Bernd F., Markus Müller, Hans Krause, et al.. (2001). Reverse transcriptase-polymerase chain reaction for prostate-specific antigen in the molecular staging of pelvic surgical margins after radical prostatectomy. Urology. 57(5). 1006–1011. 2 indexed citations
8.
9.
Straub, Bernd F., Markus Müller, Mark Schrader, Rüdiger Heicappell, & Kurt Miller. (2001). OSTEOPOROSIS AND MILD METABOLIC ACIDOSIS IN THE RAT AFTER ORCHIECTOMY AND THEIR PREVENTION: SHOULD PROPHYLACTIC THERAPY BE ADMINISTERED TO PATIENTS WITH ANDROGEN DEPRIVATION?. The Journal of Urology. 165(5). 1783–1789. 7 indexed citations
10.
Heicappell, Rüdiger, Markus Müller, Rolf Fimmers, & Kurt Miller. (2000). Qualitative Determination of Urinary Human Complement Factor H-Related Protein (hcfHrp) in Patients with Bladder Cancer, Healthy Controls, and Patients with Benign Urologic Disease. Urologia Internationalis. 65(4). 181–184. 23 indexed citations
11.
Straub, Bernd F., et al.. (2000). RECURRENT INTRALUMINAL URETERAL METASTASIS OF A TESTICULAR SEMINOMA. The Journal of Urology. 164(2). 443–444. 3 indexed citations
12.
Schrader, Mark, Markus Müller, Rüdiger Heicappell, et al.. (2000). Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients. Fertility and Sterility. 73(4). 706–711. 15 indexed citations
13.
Goessl, Carsten, Hans Krause, Markus Müller, et al.. (2000). Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.. PubMed. 60(21). 5941–5. 217 indexed citations
14.
Müller, Markus, Rüdiger Heicappell, Hans Krause, Anja Dankof, & Kurt Miller. (1999). DIAGNOSIS OF BLADDER CANCER BY DETECTING DIFFERENT TELOMERASE-SUBUNITS IN URINE. The Journal of Urology. 153–153. 2 indexed citations
15.
Goessl, Carsten, et al.. (1999). TUMOR DNA IN THE BLOOD PLASMA OF PATIENTS WITH CLEAR CELL RENAL CARCINOMA. The Journal of Urology. 144–144. 3 indexed citations
16.
Heicappell, Rüdiger, et al.. (1999). UROTHELIAL CARCINOMA IN A SUPRAPUBIC CYSTOSTOMY TRACT 27 YEARS AFTER TUBE REMOVAL. The Journal of Urology. 162(3 Part 1). 797–798. 1 indexed citations
17.
Heine, Bernhard, Michael Hummel, Markus Müller, et al.. (1998). Non‐radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. The Journal of Pathology. 184(1). 71–76. 43 indexed citations
18.
Müller, Markus, et al.. (1997). Side Effects of Chemotherapy for Advanced Urothelial Carcinoma with Etoposide and Ifosfamide. Urologia Internationalis. 59(4). 248–251. 4 indexed citations
19.
Heicappell, Rüdiger & R. Ackermann. (1991). Immunomodulation of advanced/progressive renal cell cancer. Current Opinion in Urology. 1(1). 38–46. 1 indexed citations
20.
Pohl, Jens, Adriana Radler‐Pohl, Rüdiger Heicappell, & Volker Schirrmacher. (1988). Oncogene expression in related cancer lines differing in metastatic capacity. Clinical & Experimental Metastasis. 6(3). 201–211. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frances M. Martin Breakdown of academic impact, for papers by Lucie Hamel Breakdown of academic impact, for papers by Céu Costa Breakdown of academic impact, for papers by Jian Gu Breakdown of academic impact, for papers by Lujia Zou Breakdown of academic impact, for papers by Yi Liao Breakdown of academic impact, for papers by K Yamanaka Breakdown of academic impact, for papers by Laura N. Mutton Breakdown of academic impact, for papers by Alicia Malewska Breakdown of academic impact, for papers by Dolores Byrne
Rankless by CCL
2026